MicroRNA-135a-3p is downregulated and serves as a tumour suppressor in ovarian cancer by targeting CCR2

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• MicroRNAs (miRNAs) are key regulators in cancer development.
• miR-135a family members, including miR-135a-5p and miR-135a-3p, show tumor-suppressive roles in various cancers.
• The specific function and molecular mechanisms of miR-135a-3p in ovarian cancer remain unclear.

Purpose of the Study:

• To investigate the role of miR-135a-3p in ovarian carcinoma.
• To elucidate the molecular mechanisms by which miR-135a-3p affects ovarian cancer cell growth and metastasis.

Main Methods:

• Quantitative analysis of miR-135a-3p expression in ovarian cancer tissues.
• In vitro assays assessing the effects of miR-135a-3p overexpression on cell proliferation, migration, and invasion.
• Luciferase reporter assays to identify miR-135a-3p targets.
• In vivo studies using xenograft models.

Main Results:

• miR-135a-3p expression is significantly downregulated in ovarian carcinoma tissues.
• Overexpression of miR-135a-3p inhibits ovarian cancer cell proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT).
• C-C chemokine receptor type 2 (CCR2) is identified as a direct target of miR-135a-3p.
• CCR2 depletion mimics miR-135a-3p's inhibitory effects, and CCR2 overexpression rescues these effects.
• miR-135a-3p suppresses tumor growth in vivo by targeting CCR2.

Conclusions:

• miR-135a-3p functions as a tumor suppressor gene in ovarian cancer.
• The tumor-suppressive role of miR-135a-3p is mediated through the regulation of CCR2.
• miR-135a-3p represents a potential therapeutic target for ovarian cancer treatment.